key: cord-0696834-swhuo8gb
authors: Daniel, Evangeline Ann; Esakialraj L, Bennett Henzeler; S, Anbalagan; Muthuramalingam, Kannan; Karunaianantham, Ramesh; Karunakaran, Lucia Precilla; Nesakumar, Manohar; Selvachithiram, Murugesan; Pattabiraman, Sathyamurthi; Natarajan, Sudhakar; Tripathy, Srikanth Prasad; Hanna, Luke Elizabeth
title: Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review
date: 2021-05-17
journal: Diagn Microbiol Infect Dis
DOI: 10.1016/j.diagmicrobio.2021.115432
sha: 13040132b5c7ca3bb551b52988bc17622b90cf74
doc_id: 696834
cord_uid: swhuo8gb

SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them ‘en bloc’. Only if the pool tests positive, retesting of individual samples is performed. Upon reviewing recent articles on this strategy employed in various SARS-CoV-2 testing scenarios, we found substantial diversity emphasizing the requirement of a common protocol. In this article, we review various theoretically simulated and clinically validated pooled testing models and propose practical guidelines on applying this strategy for large scale screening. If implemented properly, the proposed approach could contribute to proper utilization of testing resources and flattening of infection curve.

A novel coronavirus was recognized as the pathogen responsible for the chronic cases of pneumonia that were reported in Wuhan, China in late December 2019 (Andersen et al., 2020; Zhou et al., 2020) . This virus was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 . Due to its extensive transmission across the globe, COVID-19 was declared as a pandemic by the World Health Organization on 11 March 2020 (Cucinotta and Vanelli, 2020) . As of 9 February 2021, the WHO has reported 105.4 million cases and 2.3 million deaths worldwide n.d.) . Owing to limited monitoring capacity, diagnostic testing is often limited to symptomatic individuals or people with underlying risk factors for chronic diseases and healthcare workers. A significant proportion of potentially infectious carriers in the community remain undiagnosed, since a majority of population are asymptomatic or present with mild symptoms (Wu and McGoogan, 2020) . However, it has been documented that asymptomatic individuals can very well transmit SARS-CoV-2 (Rothe et al., 2020; Ye et al., 2020) . With gradual evolution of the pandemic over the last few months, diagnostic centres encounter new challenges in performing surveillance screening of asymptomatic population, driving test numbers even beyond those executed during the peak of the pandemic. Therefore, it is vital to amplify the screening capacity for index case isolation and contact tracing to prevent further spread. The primary diagnostic test that has been employed worldwide to screen COVID-19 is the Real-Time Reverse Transcriptase-Polymerase Chain reaction (RT-PCR) with acceptable sensitivity and specificity levels (Corman et al., 2020) . But even in developed countries, testing by RT-PCR is highly constrained due to shortage of reagents and the limited tests that can be performed in a single run. In addition to this, low-income countries with inadequate resources cannot afford the test. Therefore, a rapid, widespread and cost-effective testing strategy is required to curb further spread. A promising strategy to escalate screening capacity is to pool multiple samples in a single test. Pooled testing (pooling or group testing) involves the screening of a sample pool comprising of multiple individual samples, followed by individual testing (pool deconvolution) only of pools that test positive. A pool that tests negative implies a negative result for all individual samples in the pool. This potentially leads to a much larger number of people being tested when compared to individual testing, while keeping the number of tests the same thereby accelerating the throughput of the existing testing infrastructure (Hanel and Thurner, 2020) .

Pooling bears the advantage of estimating the positivity rate in a population with fewer tests.

It also reduces the testing time. This strategy of grouping samples was pioneered by Robert

Dorfman in 1943 to screen men with syphilis in the US military (Dorfman, 1943) .

Thenceforth, pooling of samples has been used as a screening strategy in multiple infectious diseases like HIV (Emmanuel et al., 1988; Litvak et al., 1994; Sherlock et al., 2007; Stramer et al., 2004) , Influenza(Hourfar et al., 2007; Van et al., 2012) , Malaria (Taylor et al., 2010) and various bacterial diseases (Currie et al., 2004; Edouard et al., 2015; Singer et al., 2006) .

In this review article, we present multiple pooled testing approaches reported so far for the diagnosis of COVID-19. We evaluate the efficiency of these methods and provide insights on their practical relevance. We also provide a meta-analysis of various clinical studies that successfully employed pooled testing. Using the practical guidelines furnished, pooling protocols can be framed by testing centres to increase their diagnostic capacity.

Effective application of pooled testing requires baseline parameters like the prevalence rate of the population, sensitivity and specificity of the test and limit of detection. A key step in this approach is to ascertain an ideal pool size that conserves maximum resources with consistent testing performance (Abdalhamid et al., 2020b) . In multiple recent articles and preprints, ideal batch sizes for different ranges of prevalence along with the expected reduction in fraction of tests and costs are put forth based on various algorithms (Aragón-Caqueo et al., 2020; Brynildsrud, 2020; Gu et al., 2020; Rai et al., 2020; Regen et al., 2020; Tan et al., 2020) Pooled testing works on two paradigms, adaptive and non-adaptive testing. Adaptive pooling is a sequential multi-stage grouping design. In this method, the pool results of the former stage impact the pooling strategy of the consecutive stages. Non-adaptive pooling methods involve parallel testing of multiple pools in a single stage.

In this approach, the tests are performed sequentially. A group is randomly selected based on predicted prevalence rate and tested. The outcome of this test determines the next group to test and so on. Thus, the size and samples of a pool are chosen adaptively based on a previous pool and its test outcome (Mentus et al., 2020) .

Dorfman Pooling is the simplest form of pooled testing wherein a set of individual samples are clustered into a pool. If the pool tests positive, it is deconvoluted to decrypt the positive individuals. If the pool is tested negative, all the individuals in the group are interpreted as negative (Dorfman, 1943) . Dorfman testing is the most preferred pooling method in clinical scenarios although it usually utilises the highest number of tests among all pooling approaches.

In Binary splitting, instead of performing individual tests of a positive group as in Dorfman's method, the pool is further divided into two equal sized sub-pools and tested again. The subpool that tests positive is split in the next stage until all the negative pools are excluded (Litvak et al., 1994) . Binary method is feasible with a maximum of four steps since several dividing steps can be time consuming.

Multistage model involves sampling different pool sizes at different stages contrary to the binary split method, which uses just two pools in every stage. The number of tests and stages are also substantially minimized. A three-stage testing scheme with pool size of 16 samples in a prevalence rate of 5% has an efficiency gain of 3. A lower prevalence rate favours large pool size and multiple stages while smaller pool sizes with lesser number of stages are to be chosen in higher prevalence settings (Eberhardt et al., n.d.) . Gajpal et al employed dynamic

programming and have furnished details on the optimum stages required for different sample sizes (Gajpal et al., 2020) .

In case of a homogenous population like a locality or neighbourhood, an exposed individual has high chances of spreading the disease immediately to families, neighbours, etc., In this approach, the first step involves forming optimum sized pools of a homogenous population followed by swab tests for all members of the pool. In a second step, positively tested pools will be retested individually. In a population of 150 000, this method can lead to reduction of existing tests by around 56% in moderate prevalence settings with pool sizes up to 25 (Deckert et al., 2020; Takyi-Williams, 2020) .

The storing of multiple samples and rerunning of RT-PCR makes lab organization for adaptive approach a resource intensive process. The diagnosis process is liable to delays because of the follow-up loop. Fig.1A -C represents various adaptive pooled testing models that are implemented for COVID-19 diagnosis.

In the non-adaptive approach, each sample is distributed over multiple pools, and all the tests are simultaneously run in parallel yielding reliable results after one round of testing. With increase in pool size and sample multiplicity, a gradual rise in the number of false positives is expected. But initial observation of the prevalence rate and calculation of the explicit error bounds of the false positives leads to streamlined testing and reduced detection times for mass screening (Täufer, 2020) .

Matrix or array testing is a high throughput non-adaptive screening procedure originally proposed by Phatarfod and Sudbury (Phatarfod and Sudbury, 1994) . This approach involves constructing a matrix-like grid of samples and grouping samples within rows and columns of the matrix. Unlike adaptive testing, where individuals are consigned to one pool, here each sample will be distributed in two or more individual pools. Samples that traverse the positive rows and columns are tested individually to diagnose the positive cases whereas samples present outside the row-column intersections are declared negative.

A recent article proposes to arrange samples in the geometry of a hypercube by grouping along its hyperplanes thereby allocating each member in pool sizes of three or more. Based on the viral prevalence, a pool size N = 3D (D= dimension) is determined initially. With decrease in prevalence, D rises, leading to reduced number of tests. Fig. 2 depicts pooling based on hypercube algorithm. This algorithm was validated in oropharyngeal swabs in Rwanda, with precise diagnostic accuracy even after a 100-fold dilution (adding 99 negative samples to one positive sample). In a prevalence setting of less than 0.01%, an improvement of 400 times efficiency compared to regular testing was observed (Mutesa et al., 2021) . But an intersection of any two hyperplanes in more than one point might occur in dimensions above three. This might impair testing efficiency by creating unnecessary correlations between different pools.

In compressed sensing, the result is not just a binary reading (positive or negative), but also reveals the viral loads (copies/mL) of individuals who test positive (Ghosh et al., 2020a; Yi et al., 2020) .

In this approach, samples are stratified on the basis of Reed-Solomon error correction. P-BEST was tested using four sets of 384 samples, each containing positive cases ranging from two to five. This method was able to correctly identify all positive cases using only 48 tests with a testing efficiency gain of 8. Modelling algorithms report very less false positive and negative numbers (<2.75 and <0.33 respectively) utilising P-BEST decoding (Shental et al., 2020) .

Tapestry pooling is a single round testing where each individual is assigned to three different groups. The algorithm takes ct values from the pooled RT-PCR tests as input and yields the output result. If the sample is tested positive, an estimated viral titre is also provided. An app has also been developed to facilitate implementation in clinical laboratory settings. The method has been shown to work in vitro with zero false positives and false negatives.

Validation in clinical samples is ongoing (Ghosh et al., 2020b; Gopalkrishnan and Krishna, 2020) .

A foremost requisite of any modelling algorithm is the successful translation of theoretical simulations into clinically relevant applications. There are effective feasibility studies of various pooling methods in SARS-CoV-2 diagnosis. Studies have also compared pooled testing with naïve testing to ensure that detection accuracy is not compromised. Table 1 summarizes different studies worldwide that have validated pooled testing in various pool sizes and prevalence rates. Four different pooling strategies have been employed so far in clinical setups (Fig. 3) . The most common method is to collect the samples and pool them just Though the turn-around time is swift in this method, it does not save many resources. Swab pooling in a single tube at the time of collection is another practice. This is found to be as sensitive as individual testing (Christoff et al., 2021) but if a positive pool is encountered, samples have to be collected again. Hence double swabs have to be collected from every individual in the beginning (Chen et al., 2020) . A couple of studies have directly collected the samples in lysis buffer instead of the viral transport media (VTM) to avoid dilution. This direct pooling also inactivates the virus easing the extraction process Wacharapluesadee et al., 2020) . Owing to the non-invasive nature of sample collection, the feasibility of utilising pooled saliva has also been tested and found that detection is possible without much compromise in sensitivity (Barat et al., 2020; Fogarty et al., 2020; Pasomsub et al., 2020) . Studies have reported improved test turn-around time and conservation of laboratory resources while adapting pooled testing (Abdalhamid et al., 2020a; Agoti et al., 2020) . The diagnostic accuracy while adapting pooled testing is found to be highly efficient in most of the studies (Fig.4) . The WHO has furnished an acceptable level of ≥80% sensitivity and ≥97% specificity for COVID-19 diagnostics in the Target Product Profile (TPP).

Other works over the last few months have suggested refined models, from a more theoretical viewpoint with real world data as example. In a 2% prevalence rate, a matrix-based 96 well pooling is predicted to reduce tests up to four-fold while an eight-fold reduction is expected at 0.5% prevalence(Sinnott-Armstrong et al., 2020). A simulation study based on the available positivity rate data proposes an optimum pool size of up to 32 for a population of 10 000 (Bukhari et al., 2020) . With the underlying prevalence rate of 2% in South Korea, sample stratification in pools up to 16 using a multi-stage scheme allows a five -fold efficiency gain relative to individual testing (Eberhardt et al., n.d.) . Other simulation models and algorithms have also been proposed (Chow and Chow, 2021; Nalbantoglu, 2020; Pilcher et al., 2005; Polage et al., 2020; Vukičević and Polašek, 2020) .

The diagnostic screening of SARS-CoV-2 can be performed in a lesser time span by pooling samples. It is also evident that testing in pools substantially reduces the number of reagents, 

With gradual relaxation in lockdown rules, reopening of Universities and schools and resumption of transport, it is critical to ramp up the numbers of testing of asymptomatic population. By comparing various pooled testing strategies implemented so far, we put forth the optimal choice for various scenarios.

a) For community surveillance in resource limited settings with inadequate testing facilities, a door-to-door approach is suitable. Asymptomatic people in households and localities can be tested using this approach. Individual samples from houses in close vicinity can be pooled together considering the spatial clustering of the outbreak in a particular area. This can be organized by mapping the region, plotting the households in the locale and pooling samples from adjoining houses. b) Binary splitting algorithms can be employed to test market vendors, bank and supermarket agents and other frontline workers who were actively exposed during the lockdown enforced by the Government.

c) Routine screening of health care workers and hospital staff can be done with Matrix

Pooling since it involves a single round of tests. d) When the testing speed is a primary factor, it may be feasible to employ Multistage testing as it enables us to perform parallel group tests e) Hypercube algorithm can find application in regular testing of players and staff of sports teams.

At the beginning of each test, it is vital to estimate the positivity rate. Based on the empirical results received from a specific laboratory in a population, the rate of positive tests should be updated on a daily basis.

a) Medical councils from across the globe have recommended to use a pool size of 5. But in areas with prevalence lesser than 1%, the pool size can go up to 10 based on clinical validation studies around the world. It is always important to restrict pooled testing approach for prevalence up to 5%. As prevalence increases, the efficiency of the pooled testing flattens.

b) Web based applications like shiny app (https://bilder.shinyapps.io/PooledTesting/) (Hou et al., 2020) can also be used to determine the efficient pool size based on parameters like prevalence, sensitivity and specificity of the assay.

Proceed with RT-PCR of each pool, neglect negative pools, deconvolute positive pools.

Testing in pools has the potential to substantially expand the testing capacity and lower the limitations present in the current diagnostic tests for SARS-CoV-2. Studies have reported considerable increase in testing throughput and detection efficiency with consistent levels of sensitivity and specificity. Thus, pooled testing is a feasible method to circumvent the bottlenecks in the existing testing methods of COVID-19. Given the successful implementation of this strategy in different countries, the approach may find applicability in routine community surveys.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. '-' indicates that studies that did not report prevalence rate at the time of testing and the resources saved 

Cost Effectiveness of Sample Pooling to Test for SARS-CoV-2

Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources

Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia

Pooled nasopharyngeal swab collection in a single vial for the diagnosis of SARS CoV-2 infection: An effective cost saving method

Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling

The proximal origin of SARS-CoV-2

Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model

Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests. Infectious Diseases (except HIV/AIDS)

Pooled Saliva Specimens for SARS-CoV-2 Testing

Assessing the dilution effect of specimen pooling on the sensitivity of SARS-CoV-2 PCR tests

Largescale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection

Pooling of Upper Respiratory Specimens Using a SARS-CoV-2 Real-time RT-PCR Assay Authorized for Emergency Use in Low-Prevalence Populations for High-Throughput Testing

COVID-19 prevalence estimation by random sampling in populationoptimal sample pooling under varying assumptions about true prevalence

Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits

Pooling for SARS-CoV-2 control in care institutions

Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19

Validation of SARS CoV-2 detection by real-time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: a study in tertiary care hospital of North India

A discussion on implementing pooling detection tests of novel coronavirus (SARS-CoV-2) for a large population

Efficient prevalence estimation and infected sample identification with group testing for SARS-CoV-2

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

COVID-19 situation reports

WHO Declares COVID-19 a Pandemic

Pooling of clinical specimens prior to testing for Chlamydia trachomatis by PCR is accurate and cost saving

Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals

Simulation of pooled-sample analysis strategies for COVID-19 mass testing

Analysis of multi-sample pools in the detection of SARS-CoV-2 RNA for mass screening: An Indian perspective

Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus -Duke University

The Detection of Defective Members of Large Populations

Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening

Cost-Effective Pooling of DNA from Nasopharyngeal Swab Samples for Large-Scale Detection of Bacteria by Real-Time PCR

Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples

Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries

Optimizing RT-PCR detection of SARS-CoV-2 for developing countries using pool testing

Pooled saliva samples for COVID-19 surveillance programme

Sample pooling of RNA extracts to speed up SARS-CoV-2 diagnosis using CDC FDA EUA RT-qPCR kit

Optimal Multi-Stage Group Partition for Efficient Coronavirus Screening

Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens

A Compressed Sensing Approach to Group-testing for COVID-19 Detection

Tapestry: A Single-Round Smart Pooling Technique for COVID-19 Testing

Pooling Samples to Increase SARS-CoV-2 Testing

Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay

Assessment of sample pooling for clinical SARS-CoV-2 testing

A cost-effective plan for global testing -an infection rate stratified, algorithm guided, multiple-level, continuously pooled testing strategy

Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: A reliable, faster and economical method

Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients

Comparison of three commercial SARS-CoV-2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics

Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2

Array testing for multiplex assays

Optimal size of sample pooling for RNA pool testing: An avant-garde for scaling up severe acute respiratory syndrome coronavirus-2 testing

Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR

Real-time Screening of Specimen Pools for Coronavirus Disease 2019 (COVID-19) Infection at Sanya Airport

A novel strategy for community screening of SARS-CoV-2 (COVID-19): Sample pooling method

Screening for the Presence of a Disease by Pooling Sera Samples

Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. The Lancet Infectious Diseases 2020

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Pooled Testing for SARS-CoV-2 in Hospitalized Patients

Analysis and Applications of Adaptive Group Testing Methods for COVID-19

Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2

Pooling of Nasopharyngeal (NP) Swab Samples to Overcome Global Shortage of rRT

A pooled testing strategy for identifying SARS-CoV-2 at low prevalence

Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing

Saliva sample pooling for the detection of SARS-CoV-2

Pooling of SARS-CoV-2 samples to increase molecular testing throughput

The use of a square array scheme in blood testing

Detection of Acute Infections during HIV Testing in North Carolina

Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations

Pooled testing for COVID-19 diagnosis by real-time RT-PCR: A multi-site comparative evaluation of 5-& 10-sample pooling

Asymptomatic Patient Testing After 10:1 Pooling Using the Xpert Xpress SARS-CoV-2 Assay

Pool Testing for COVID-19: Suitable Splitting Procedure and Pool Size for India

A simple approach to optimum pool size for pooled SARS-CoV-2 testing

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Sample pooling for SARS-CoV-2 RT-PCR screening

Pooling samples: a testing option for SARS-CoV-2 during a supply shortage

Novel multiple swab method enables high efficiency in SARS-CoV-2 screenings without loss of sensitivity for screening of a complete population

Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing

Efficient highthroughput SARS-CoV-2 testing to detect asymptomatic carriers

Routine detection of acute HIV infection through RNA pooling: survey of current practice in the United States

Use of pooled samples for the detection of Salmonella in feces by polymerase chain reaction

Evaluation of pooled sample analysis strategy in expediting case detection in areas with emerging outbreaks of COVID-19: A pilot study

Evaluation of Group Testing for SARS-CoV-2 RNA

Impact of Pool Testing in Detection of Asymptomatic Patients with COVID-19

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acidamplification testing

Household representative sample strategy for COVID-19 large-scale population screening

Considerations for Group Testing: A Practical Approach for the Clinical Laboratory

Rapid, large-scale, and effective detection of COVID-19 via non-adaptive testing

High-throughput pooling and real-time PCR-based strategy for malaria detection

The Application of Sample Pooling for Mass Screening of SARS-CoV-2 in an Outbreak of COVID-19 in Vietnam

Pooling nasopharyngeal/throat swab specimens to increase testing capacity for influenza viruses by PCR

Pooling of samples to optimize SARS-CoV-2 diagnosis by RT-qPCR: comparative analysis of two protocols

Optimizing the diagnostic capacity for COVID-19 PCR testing for low resource and high demand settings: The development of information-dependent pooling protocol

Evaluating the efficiency of specimen pooling for PCR-based detection of COVID

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Pooling saliva to increase SARS-CoV-2 testing capacity

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster

Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools

Low-Cost and High-Throughput Testing of COVID-19 Viruses and Antibodies via Compressed Sensing: System Concepts and Computational Experiments

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Data collection, curation and Analysis Kannan Muthuramalingam: Data collection, curation and Analysis Ramesh Karunaianantham: Data collection, curation and Analysis

Lucia Precilla Karunakaran: Data collection, curation and Analysis

Manohar Nesakumar: Data collection, curation and Analysis; Reviewing and editing draft Murugesan Selvachithiram: Data curation and analysis Sathyamurthi Pattabiraman: Data curation and analysis

Sudhakar Natarajan: Data curation and analysis; Reviewing and editing draft Srikanth Prasad Tripathy: Supervision